The Monitor Daily

Sunday, January 24, 2021
Log in

As a participant in the Amazon Services LLC Associates Program, this site may earn from qualifying purchases. We may also earn commissions on purchases from other retail websites.

  • Home
  • Politics & National News
  • Business News
  • Tech & Science
  • Health & Lifestyle
  • About us
    • Contact US
    • Privacy Policy GDPR
    • Terms of Use
  • Latest News
    • Stormy Planet
    • US Surgeon Performs Face Transplant
    • 2017 MTV VMAs Nominations Are In And Voting Is Now Open
    • Bright House: Free McAfee AntiVirus and Adult Controls
    • Antarctic Yeti Crab Gets Formal Scientific Name
    • Spiders Take Over Australian Town
    • Interesting Facts About the Apollo 11 Mission
    • Social Smoking or The New Landmark of Elegance Among Young Women
    • Rare Weasel Returns To Washington State

Pages

  • About The Monitor Daily
  • Contact US
  • Our Team
  • Privacy Policy GDPR
  • Terms of Use

Recent Posts

  • Precisely what is Administration Buyback? Feb 12, 2020
  • Precisely what is Administration Buyback? Feb 12, 2020
  • Where by do Registered requests get kept Dec 1, 2019
  • Find a Star of the event on the Submit Purchase New bride List May 19, 2019
  • Locate Really enjoy On the internet Apr 30, 2019
  • Get Love On the net Apr 12, 2019
  • NYC Man Snaps Photo of the Victim After Sucker-Punching Him in Broad Daylight Jun 29, 2018

BioMarin’s Drisapersen Commercialization Gets Denied by the FDA

By Leave a Comment

"wheelchair in a forest"

There are almost 60,000 people on Earth which currently suffer from DMD.

For people, especially children, suffering from Duchenne muscular dystrophy, the news that BioMarin’s drisapersen commercialization gets denied by the FDA is extremely dire to say the least. Although several parents that have children which suffer from this illness have stated that after treatment with drisapersen during clinical trials, their offspring’s health improved, FDA’s decision is final

One of the factors which make parents criticize the Food and Drug Administration’s decision is how drisapersen treatments would have been marked at $300,000 per month, requiring them to be covered by insurance. It’s safe to say that FDA’s dismissal of the drug came as a devastating blow for both the 2,430 boys suffering from Duchene Muscular Dystrophy and their parents.

DMD is a genetic disease that consists of a massively reduced production of a protein used in the strengthening of muscles, named dystrophin. By lacking the required amounts of protein intake, muscles eventually degenerate. Diagnosis with DMD usually occurs in boys aged between 3 or 5 years old.

Most diagnosed patients will require wheelchairs when they reach their teens, with muscles no longer able to withstand the body’s weight. After that point, severe respiratory and heart problems will start to surface. The lifespan of a DMD diagnosed patient is of about 30 years.

Currently, there are no DMD treatments approved by the FDA, making parents heavily criticize the administration’s inflexibility towards allowing drisapersen to be made commercially available. The FDA has stated that the reason for their decision is based on the drug’s close to 0 benefit towards an increased production of dystrophin.

By selling this drug, BioMarin would have made an estimated $600 million in sales, boosting the company’s total market values and share prices by a rather significant amount. Unfortunately, once the FDA’s was made public, BioMarin’s shares dropped by 10%.

The drug drisapersen functions by altering the genetic code of exons, portions of the DNA that act as blueprints, in order to create a higher production of dystrophin. This technique, known as exon-skipping, has been approached by other pharmaceutical companies as well.

The drug eteplrisen, manufactured by Sarepta Therapeutics will be reviewed by the FDA advisory board on the 22nd of January. But even if this new drug gets FDA approval, it will still have to circumvent hindrances posed by BioMarin which patented the exon-skipping technique.

Although BioMarin’s drisapersen commercialization gets denied by the FDA, DMD diagnosed patients still have hope that eventually, the FDA will approve a treatment in order to help them live a normal life, regardless of the company which manufactures the drug.

Image source:www.pixabay.com

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Health & Lifestyle Tagged With: BioMarin's Drisapersen Commercialization Gets Denied by the FDA, Duchenne muscular dystrophy, FDA approval, gene exon-skipping, muscle degredation, short life-span, unable to stand, wheelchair confinement

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 34 other subscribers

Operation Paperclip

Remembering Georg von Tiesenhausen, Last Member of Von Braun’s Rocket Team

By Leave a Comment

giant ground sloths on white background

It Seems that Giant Sloths Once Roamed Earth, and Humans Used to Hunt Them? (Study)

By Leave a Comment

sn 2001ig supernova explosion and images of its stars

A Star Escaped a Supernova Explosion, and NASA Snapped its Picture

By Leave a Comment

ngc 6420 galaxy resembling a giant butterfly

Hubble Spots Giant Butterfly Formed by a Black Hole and Stellar Winds (Study)

By Leave a Comment

infrared image of a dog

Space Technology Could Help Protect Earth’s Endangered Species

By Leave a Comment

snake slithering on a beige background

Kirigami Skin Is Helping a Soft Robot Slither Like a Snake (Study)

By Leave a Comment

woolly mammoth

Ice Age Tracks Reveal How Young Mammoths Cared for Adult Ones (Study)

By Leave a Comment

High Priestess tomb.

Archaeologists Discovered 4400-Years-Old High Priestess Tomb Near Cairo

By Leave a Comment

dwarf galaxies

Dwarf Galaxies Challenge the Entire Dark Matter Cosmology (Study)

By Leave a Comment

NASA Scientists and Food Experiments

NASA Scientists to Test if Astronauts Could Eat Their Own Poo

By Leave a Comment

KFC Smoky Wings Box Can Turn into Awesome Drone

By Leave a Comment

Tesla Model S

Tesla Model S Involved in Autopilot Malfunction Accident

By Leave a Comment

Duke Nukem.

John Cena Cold Feature in Duke Nukem Movie

By Leave a Comment

Battlefield One

Battlefield One Apocalypse DLC to Land in February

By Leave a Comment

Related Articles

  • eye procedure

    Queensland Mother Mutilated After Non-Invasive Eye Procedure Goes Sideways

  • HIV

    Northwest Arkansas Man Sentenced to 50 Years in Prison for Contracting HIV with the Purpose of Infecting Others

  • Meditation

    Yale Scientists Pinpointed the Brain Area for Spiritual Experiences

  • artificial intelligence

    Artificial Intelligence Outperforms Dermatologist in Melanoma Diagnosis

  • pill

    Arlington Doctor Gets 3 Years in Prison for Slipping Abortion Pill in Woman’s Tea

  • back of woman with short gray hair

    New Study Proposes Another Possible Cause for Gray Hair (Study)

  • two people jogging

    Being Physically Active Can Reportedly Make You Happier (Study)

  • OCD Twins Commit Suicide

    OCD Twins Committed Suicide, Freemont County Sheriff Confirms

  • fingerprint

    You Might Have Traces of Class A Drugs on Your Fingerprints

  • Bariatric surgery

    Star of ‘My 600-Lbs Life’ Dies of Heart Attack Following Bariatric Surgery

Categories

  • Business News
  • Entertainment
  • Featured
  • Health & Lifestyle
  • Nature
  • Politics & National
  • Sports
  • Tech & Science
  • US
  • World

Copyright © 2021 TheMonitorDaily.com

About · Privacy Policy · Terms of Use · Sitemap · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.